BIO vs BRKR: stock comparison and AI forecast
Bio-Rad Laboratories, Inc. (BIO) and Bruker Corp (BRKR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BIO Bio-Rad Laboratories, Inc.
- Price
- $369.00 +43.4% · 6M
- Market Cap
- $9.87B
- P/E Ratio
- 9.7x
- Size
- mid-cap
- AI Forecast
BRKR Bruker Corp
- Market Cap
- $8.85B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BIO is 1.1 times larger than BRKR by market capitalization ($9.87B against $8.85B).
- BIO turns 39.5% of its revenue into net income, against -3.5% for BRKR.
- BRKR carries 1.53 times debt per unit of equity, against 0.42 times for BIO.
- BRKR yields 0.35% in dividends; BIO pays none.
- Both companies share the SEC industry classification Laboratory Analytical Instruments.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BIO | BRKR |
|---|---|---|
| Market Cap | $9.87B | $8.85B |
| P/E Ratio | 9.73x | – |
| P/B Ratio | 1.30x | 3.84x |
| Dividend Yield | – | 0.35% |
| EPS | $37.91 | $-0.55 |
| Book Value/Share | $284.35 | $15.14 |
| Revenue/Share | $96.97 | $23.06 |
| FCF/Share | $12.31 | $1.61 |
Profitability & Margins
| Metric | BIO | BRKR |
|---|---|---|
| ROE | 13.4% | -5.3% |
| ROA | 9.5% | -2.1% |
| ROIC | -0.6% | -1.5% |
| Gross Margin | 51.3% | 47.7% |
| Operating Margin | -2.4% | -2.0% |
| Net Margin | 39.5% | -3.5% |
| EBT Margin | 50.9% | -2.0% |
| Tax Rate | 22.5% | -59.7% |
Financial Health
| Metric | BIO | BRKR |
|---|---|---|
| Current Ratio | 3.18x | 1.84x |
| Quick Ratio | 2.37x | 0.90x |
| D/E Ratio | 0.42x | 1.53x |
| Financial Leverage | 1.42x | 2.53x |
| Interest Coverage | -4.0x | -8.2x |
| Working Capital | $2.11B | $985M |
Cash Flow
| Metric | BIO | BRKR |
|---|---|---|
| Operating Cash Flow | $468M | $342M |
| Free Cash Flow | $329M | $245M |
| Capital Spending | -$139M | -$97M |
| OCF Growth YoY | -4.8% | 262.5% |
| FCF Growth YoY | -2.3% | – |
| FCF/Sales | 12.7% | 7.0% |
| CapEx/Sales | 5.4% | 2.8% |
Operational Efficiency
| Metric | BIO | BRKR |
|---|---|---|
| Asset Turnover | 0.24x | 0.60x |
| Receivables Turnover | 6.1x | 6.2x |
| Inventory Turnover | 1.6x | 1.7x |
| Fixed Assets Turnover | 5.2x | 5.0x |
| Days Sales Outstanding | 59 days | 59 days |
| Days Inventory | 226 days | 219 days |
| Payables Period | 39 days | 41 days |
| Cash Conversion Cycle | 247 days | 236 days |
Income Statement
| Metric | BIO | BRKR |
|---|---|---|
| Total Revenue | $2.59B | $3.51B |
| Operating Income | -$62M | -$70M |
| Net Income | $1.02B | -$123M |
| R&D Expense | $266M | $387M |
| SG&A Expense | $902M | $955M |
| Cost of Goods Sold | $1.26B | $1.84B |
Dividend & Shareholder Information
| Metric | BIO | BRKR |
|---|---|---|
| Dividends Per Share | – | $0.20 |
| Shares Outstanding | 27M | 152M |
| EPS Growth | 150.1% | -787.5% |
BIO vs BRKR: stock comparison and AI forecast
Which is bigger, BIO or BRKR?
BIO is 1.1 times larger than BRKR by market capitalization ($9.87B against $8.85B).
Which one does Intratio's AI model rank higher, BIO or BRKR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.